Clinical Gastroenterology Vol.39 No.02 ( Feb, 2024)

Thesis List

• 0 Editorial
  Jun Kato

• 1-1 How to Monitor IBD and How to Change Treatment
  Jun Kato

• 1-2 Shared Decision Making in Treatment Selection
  Hirono Ishikawa

• 1-3 Immunological Pathogenesis of IBD and the Rationale for the Use of Molecularly Targeted Drugs
  Tetsuya Takagawa

• 1-4 How Should Doctors Select JAK Inhibitor or Biologic Including New Interleukin-23 Inhibitor in Ulcerative Colitis Patients with Moderately Active Phase?
  Masanao Nakamura

• 1-5 Have Treatment Strategies for Acute Severe or Severe UC Changed?
  Ryosuke Horio

• 1-6 A New Era of CD Treatment with the Advent to Anti-IL-23 Antibodies and JAK Inhibitors
  Satoshi Motoya

• 2-1 IBD-associated Serrated Lesion
  Masafumi Nishio

• 2-2 Anorectal Cancer with Crohn's Disease and Darvadstrocel for the Treatment of Perianal Fistulas in CD
  Akihiko Ota

• 3-1 Anti-integrin αvβ6 Autoantibodies in Ulcerative Colitis
  Takeshi Kuwada

• 3-2 Current Status and Development of Fecal Microbiota Transplantation and Microbiome Medicine
  Dai Ishikawa

• 3-3 Intestinal Regenerative Medicine; Organoid Transplant for Inflammatory Bowel Disease
  Hiromichi Shimizu

• 3-4 Artificial Intelligence for Inflammatory Bowel Disease Clinical Practice
  Jun Miyoshi

• 3-5 The Future of IBD Telemedicine and Multi-institutional Systems
  Yuki Hayashi

Series List

• 4 What is the Difference between Depressive Erosion and Erosion of the Corpus?
  Yoshihiro Hirata

  How to Use the Kyoto Classification of Gastritis

• 5 Depth Diagnosis and IEE for Eearly Colorectal Cancer
  Toshiki Futakuchi

  Endoscopy